Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Post by retiredcfon Jul 30, 2022 12:24pm
116 Views
Post# 34862256

Another Assessment

Another AssessmentPretty much talking to myself here although there are a few readers. GLTA

Q: What is your on Neighbourly with a 3-5 year time horizon? Is there good value in purchasing this stock?

Shares are trading at 45x earnings, which is not cheap, however earnings are expected to show high and accelerating growth over the next few years in the 30% to 60% range. So we think the valuation is reasonable for the growth. The company has carved out its own niche in Canada and is implementing a roll up acquisition strategy which we believe is working well so far. NBLY has also been able to pay down debt over the last few years while growing the business. It is not profitable on an earnings basis today, but is expected to be next year and has had free cash flows since 2018. We believe shares have very good upside from these levels over a 3-5 year period. (5iResearch)


<< Previous
Bullboard Posts
Next >>